Kim-Anh Nguyen

Kim-Anh Nguyen

Auto-generated profile, based on publicly available information

Kim-Anh Nguyen

Université Paris-Saclay CEA INRAE Département Médicaments et Technologies pour la Santé (DMTS) SCBM FR-91191 Gif-sur-Yvette France

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2022 in Science Advances
Verified
Journal Article
Open access
VCvincent chaptal
vincent chaptal
VZVeronica Zampieri
Veronica Zampieri
BWBenjamin Wiseman
Benjamin Wiseman
COCédric Orelle
Cédric Orelle
JMJuliette Martin
Juliette Martin
Pierre FalsonPierre Falson
Pierre Falson
Multidrug ABC transporters translocate drugs across membranes by a mechanism for which the molecular features of drug release are so far unknown. Here, we resolved three ATP-Mg 2+ –bound outward-facing conformations of the Bacillus subtilis (homodimeric) BmrA by x-ray crystallography and single-particle cryo–electron microscopy (EM) in detergent solution, one of them with rhodamine 6G (R6G), a substrate exported by BmrA when overexpressed in B. subtilis . Two R6G molecules bind to the drug-binding cavity at the level of the outer leaflet, between transmembrane (TM) helices 1–2 of one monomer and TM5′–6′ of the other. They induce a rearrangement of TM1–2, highlighting a local flexibility that we confirmed by hydrogen/deuterium exchange and molecular dynamics simulations. In the absence of R6G, simulations show a fast postrelease occlusion of the cavity driven by hydrophobicity, while when present, R6G can move within the cavity, maintaining it open.

13 February 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
KNKim‐Anh Nguyen
Kim‐Anh Nguyen
MPMarine Peuchmaur
Marine Peuchmaur
SMSandrine Magnard
Sandrine Magnard
RHRomain Haudecoeur
Romain Haudecoeur
CBCédric Boyère
Cédric Boyère
Pierre FalsonPierre Falson
Pierre Falson

31 May 2018 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
ECElisabeta COMSA
Elisabeta COMSA
KNKim-Anh Nguyen
Kim-Anh Nguyen
FLFelicia Loghin
Felicia Loghin
ABAhcène Boumendjel
Ahcène Boumendjel
MPMarine Peuchmaur
Marine Peuchmaur
Pierre FalsonPierre Falson
Pierre Falson
Aim: Cisplatin resistance in ovarian cancer remains a complex problem as tumors frequently develop resistance against drugs, a mechanism sometimes mediated by ATP-Binding Cassette transporters. Our goal was to find compounds restricting their inhibition capacity to the cisplatin efflux mediated by ABCC2 pump, among previously identified inhibitors, derived from the 2- indolylmethylenebenzofuranones. Results/methodology: An original method setup allows direct quantitation of platinum by employing cyTOF mass cytometry. Among tested derivatives, some led to a full platinum accumulation and efficiently resensitized cisplatin-resistant A2780 cells to cisplatin while preserving most of the calcein efflux activity. Conclusion: CyTOF is therefore a powerful and promising method to quantify cisplatin accumulation that may be used in the clinical setting to improve and personalize cancer treatment.

1 October 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ECElisabeta COMSA
Elisabeta COMSA
KNKim-Anh Nguyen
Kim-Anh Nguyen
LGLucia Gonzalez-Lobato
Lucia Gonzalez-Lobato
RNRachad Nasr
Rachad Nasr
HBHélène Baubichon-Cortay
Hélène Baubichon-Cortay
Pierre FalsonPierre Falson
Pierre Falson

20 January 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EBEmeline Boukherrouba
Emeline Boukherrouba
CLCamille Larosa
Camille Larosa
KNKim-Anh Nguyen
Kim-Anh Nguyen
JCJérémy Caburet
Jérémy Caburet
LLLaurent Lunven
Laurent Lunven
MPMarine Peuchmaur
Marine Peuchmaur

25 July 2018 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
SNShweta Nim
Shweta Nim
PBPratima Baghel
Pratima Baghel
Viet-Khoa Tran-NguyenViet-Khoa Tran-Nguyen
Viet-Khoa Tran-Nguyen
BPBasile Peres
Basile Peres
KNKim-Anh Nguyen
Kim-Anh Nguyen
Ahcène BoumendjelAhcène Boumendjel
Ahcène Boumendjel
Aim: Resistance against antifungals used for Candida albicans (Ca) treatment is mediated by two multidrug transporters, Mdr1p and Cdr1p, which are of enormous interest to the development of modulators combined with antifungals. Experimental: A set of chalcones was synthesized by condensation reactions in laboratory and was then subject to biological assays to evaluate the effects on different yeast strains. Results: The obtained chalcones were screened using the checkerboard liquid chemosensitization assays. Compounds 4, 10, 12 and 18, when combined with fluconazole, triggered strong sensitization on yeast strains overexpressing CaMdr1p and CaCdr1p, whereas displaying no cytotoxicity by themselves towards control strains and transporter-expressing yeast cells. In the Nile Red transport assay, the two most active compounds, 12 and 18 showed moderate-to-high accumulation of Nile Red with different behaviors towards the two transporters. Conclusion: Chalcones are promising drug candidates for further development to make azole antifungals active again. [GRAPHICS] .